Treatment refractory hypertension. when should an endocrine etiology be considered?
Stiefelhagen, P.
MMW Fortschritte der Medizin 156 Spec no 1(1): 20
2014
ISSN/ISBN: 1438-3276 PMID: 24930337 Document Number: 673929
Document emailed within 1 workday
Related Documents
Stiefelhagen, P. 2014: Treatment refractory hypertension. When should an endocrine etiology be considered? MMW Fortschritte der Medizin 156 Spec no 1(1): 20Ling, J.-q.; Wei, X.; Liu, H.-y. 2010: Etiology and treatment strategy of refractory periapical periodontitis Zhonghua Kou Qiang Yi Xue Za Zhi 45(1): 52-57
Lamourier, E.N.; Herrmann, J.L.; Martinez, E.E.; Buffolo, E.; De Andrade, J.C.; Korkes, H.; Schubsky, V.; Ferreira, C.; Barcellini, A.; Portugal, O.P. 1975: Aneurysmectomy as the treatment for refractory tachydardias in patients with ventricular arrhythmias of chagasic etiology Arquivos Brasileiros de Cardiologia 28(5): 549-555
Chan, L.L.; Balfe, J.W.; Hardy, B.E. 1981: Captopril treatment of refractory hypertension in children Canadian Medical Association Journal 124(3): 255-259
Heagerty, A.M.; Bing, R.F.; Thurston, H.; Swales, J.D. 1987: Nifedipine substituted for minoxidil in the treatment of refractory hypertension Journal of Human Hypertension 1(2): 83-86
Saruta, T. 1989: Pathogenesis and treatment of endocrine hypertension Nihon Rinsho. Japanese Journal of Clinical Medicine 47(9): 2013-2018
Noda, M.; Sonoda, Y.; Takemoto, M.; Kira, R. 2017: Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide No to Hattatsu 49(3): 207-210
Abe, K.; Takeuchi, K. 1990: Hypertension and prostanoids--the etiology and its implications for treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 48(6): 1246-1253
Shkrob, O.S.; Vetshev, P.S.; Kuznetsov, N.S. 1996: Diagnosis, surgical treatment and prognosis in endocrine hypertension of adrenal origin Khirurgiia 3: 17-23
Gerasimenko, P.P. 1976: Diagnosis and results of surgical treatment of arterial hypertension of endocrine-adrenal origin Kardiologiia 16(5): 32-38
Danilov, N.M.; Matchin, I.G.; Chazova, I.E. 2012: Endovascular radiofrequency denervation of renal arteries as an innovation method of treatment of refractory arterial hypertension. first experience in Russia Angiologiia i Sosudistaia Khirurgiia 18(1): 51-54
Cummings, Y.E.; Dillard, M.G. 1974: Treatment of malignant hypertension. the influence of etiology on the survival in 12 consecutive patients Journal of the National Medical Association 66(2): 104-107 Passim
Martynov, A.I.; Ostroumova, O.D.; Rolik, N.L. 1997: Arterial hypertension in elderly and senile patients: etiology, symptoms, diagnosis and treatment Klinicheskaia Meditsina 75(12): 8-14
Stawiński, S.; Kleszcz, A.; Spaltenstein, W. 1978: Oxygen hypertension in the treatment of receptive auditory disorders of the cochlear type and unknown etiology Otolaryngologia Polska 32(6): 607-611
Kelly, W.K. 1998: Endocrine withdrawal syndrome and its relevance to the management of hormone refractory prostate cancer European Urology 34(Suppl): 18-23
Kawaguchi, T.; Mayama, I.; Iwabuchi, I.; Ogasawara, M.; Tsukui, A. 2010: Chemo-endocrine therapy with low-dose cisplatin, UFT, and dexamethasone for hormone-refractory prostate cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1921-1925
Neill, P. 1988: Refractory hypertension Central African Journal of Medicine 34(2): 37-38
Kraljić, I.; Tarle, M. 1987: Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors Progress in Clinical and Biological Research 243b: 521-525
Monteiro, A.A.; Carvalho, J.; Silva, J.A.; Quintas, M.B.; Maciel, L.; Azevedo, M.E.; De Freitas, A.F. 1985: Captopril in severe and refractory hypertension Arquivos Brasileiros de Cardiologia 44(3): 213-217
Gürke, T. 1998: Therapy refractory arterial hypertension Praxis 87(48): 1662-1663